Alphamab Oncology (9966.HK) HKSE
9.45
-0.12(-1.25%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.45
-0.12(-1.25%)
Currency In HKD
| Market Cap | 8.46B |
| Enterprise Value | 8.33B |
| P/E Ratio | -70.48 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 14.11 |
| Price/Book Ratio | 4.6 |
| Enterprise/Revenue | 13.87 |
| Enterprise/EBITDA | -88.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.2 |
| Operating Margin | -0.27 |
| Return On Assets | -0.05 |
| Return On Equity | -0.06 |
| Revenue | 551.58M |
| Revenue/Share | 0.59 |
| Gross Profit | 426.67M |
| EBITDA | -86.31M |
| Net Income | -110.99M |
| Diluted EPS | -0.12 |
| Total Cash | 1.35B |
| Total Cash/Share | 1.41 |
| Total Debt | 123.03M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 5.67 |
| Book Value Per Share | 1.78 |
| 52-Week Change | 43.18 |
| 52-Week High | 15.75 |
| 52-Week Low | 6.01 |
| Moving Average 50 Days | 9.46 |
| Moving Average 200 Days | 10.25 |
| Average Volume | 1.58M |
| Shares Outstanding | 968.57M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |